Advertising Age Article Abstract

New Facebook Policy Spurs Big Pharma to Rethink Social Media Strategy

Major Marketers Fear that Enabling Comments Will Attract FDA Ire

Pharmaceutical marketers are trying hard to embrace social media, but the very nature of the two-way dialogue endemic to the medium threatens to work against them. Case in point: Facebook's new poliicy. ...

Full Article Word count: 865

Become an Ad Age Subscriber

Ad Age is committed to providing you with industry news and information you need to succeed. That's why we are pleased to offer our readers 7 free articles and blogs at no charge. You have reached your 8th article. We invite you to subscribe so you can finish this article, and get uninterrupted service and access to special offers.

SUBSCRIBE NOW LOGIN
Corporate Subscriptions or Site Licenses are also available.

For questions, comments or other service issues, please contact our Customer Service Department at 1-313-446-0450.